Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 17.21
+0.36 (2.14%)
Feb 3, 2026, 1:35 PM CST
SHA:603858 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1.66 | -553.8 | 318.97 | -1,530 | 1,289 | 1,861 |
Depreciation & Amortization | 450.25 | 450.25 | 592.57 | 497.56 | 510.43 | 424.55 |
Other Amortization | 219.62 | 219.62 | 64.71 | 38.19 | 3.48 | 2.03 |
Loss (Gain) From Sale of Assets | -0.43 | -0.43 | -1.53 | -0.77 | -1.68 | -1.13 |
Asset Writedown & Restructuring Costs | 855.33 | 855.33 | 602.34 | 2,944 | 12.42 | 1.91 |
Loss (Gain) From Sale of Investments | -12.87 | -12.87 | -18.94 | 54.06 | 42.39 | -15.62 |
Provision & Write-off of Bad Debts | -25.57 | -25.57 | 8.08 | 4.41 | 15.12 | 1.45 |
Other Operating Activities | -386.37 | 55.46 | -22.29 | 72.17 | 100.81 | 107.6 |
Change in Accounts Receivable | 583.89 | 583.89 | 83.68 | 483.36 | 363.14 | -648.66 |
Change in Inventory | 228.76 | 228.76 | -1,186 | 39.52 | -1,066 | -847.77 |
Change in Accounts Payable | -820.28 | -820.28 | -493.59 | 172.01 | 92.54 | 1,058 |
Operating Cash Flow | 1,054 | 939.95 | -195.61 | 2,756 | 1,321 | 1,959 |
Operating Cash Flow Growth | 14.81% | - | - | 108.68% | -32.58% | -25.28% |
Capital Expenditures | -93.71 | -197 | -529.92 | -543.17 | -433.53 | -536.44 |
Sale of Property, Plant & Equipment | 0.3 | 0.49 | 2.4 | 0.48 | 1.45 | 10.23 |
Cash Acquisitions | - | - | 0.75 | - | -272.7 | 66.43 |
Divestitures | -0 | -0 | -0.2 | - | -0.04 | 21.66 |
Investment in Securities | -327.92 | -63.55 | 328.37 | -478.96 | -46.91 | -28.51 |
Other Investing Activities | 12.42 | 10.51 | 30.6 | 11.47 | 96.05 | 44.91 |
Investing Cash Flow | -408.92 | -249.55 | -168 | -1,010 | -655.67 | -421.72 |
Long-Term Debt Issued | - | 2,306 | 1,505 | 2,295 | 3,173 | 3,079 |
Total Debt Issued | 1,773 | 2,306 | 1,505 | 2,295 | 3,173 | 3,079 |
Long-Term Debt Repaid | - | -1,905 | -1,355 | -2,722 | -3,154 | -2,438 |
Total Debt Repaid | -1,862 | -1,905 | -1,355 | -2,722 | -3,154 | -2,438 |
Net Debt Issued (Repaid) | -88.94 | 401.54 | 150.1 | -426.96 | 18.9 | 641.75 |
Repurchase of Common Stock | -702.34 | -702.34 | -9.99 | - | - | - |
Common Dividends Paid | -530.79 | -272.44 | -1,194 | -547.34 | -746.21 | -2,488 |
Other Financing Activities | 586.34 | 8.02 | -11.24 | -13.27 | -43.57 | -39.5 |
Financing Cash Flow | -735.73 | -565.21 | -1,065 | -987.57 | -770.88 | -1,886 |
Foreign Exchange Rate Adjustments | 0 | 0.01 | 0.01 | 0.16 | -0.34 | -0.01 |
Net Cash Flow | -91.07 | 125.2 | -1,429 | 758.04 | -106.38 | -348.95 |
Free Cash Flow | 959.86 | 742.96 | -725.52 | 2,212 | 886.98 | 1,422 |
Free Cash Flow Growth | 64.13% | - | - | 149.44% | -37.64% | -27.40% |
Free Cash Flow Margin | 8.76% | 6.75% | -5.48% | 14.80% | 5.63% | 8.89% |
Free Cash Flow Per Share | 0.91 | 0.69 | -0.66 | 2.00 | 0.80 | 1.29 |
Cash Interest Paid | - | - | - | 5.02 | - | - |
Cash Income Tax Paid | 1,327 | 1,419 | 1,819 | 1,915 | 2,308 | 2,116 |
Levered Free Cash Flow | 1,351 | 1,368 | -558.66 | 1,955 | 915.43 | 869.9 |
Unlevered Free Cash Flow | 1,428 | 1,449 | -489.95 | 2,040 | 1,020 | 960.56 |
Change in Working Capital | -48.05 | -48.05 | -1,740 | 675.49 | -651.7 | -422.91 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.